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Abstract
Background: Dictyostelium cells secrete the proteins AprA and CfaD. Cells lacking either AprA
or CfaD proliferate faster than wild type, while AprA or CfaD overexpressor cells proliferate
slowly, indicating that AprA and CfaD are autocrine factors that repress proliferation. CfaD
interacts with AprA and requires the presence of AprA to slow proliferation. To determine if CfaD
is necessary for the ability of AprA to slow proliferation, whether AprA binds to cells, and if so
whether the binding requires the presence of CfaD, we examined the binding and effect on
proliferation of recombinant AprA.
Results: We find that the extracellular accumulation of AprA increases with cell density and
reaches a concentration of 0.3 μg/ml near a stationary cell density. When added to wild-type or
aprA- cells, recombinant AprA (rAprA) significantly slows proliferation at 0.1 μg/ml and higher
concentrations. From 4 to 64 μg/ml, the effect of rAprA is at a plateau, slowing but not stopping
proliferation. The proliferation-inhibiting activity of rAprA is roughly the same as that of native
AprA in conditioned growth medium. Proliferating aprA- cells show saturable binding of rAprA to
92,000 ± 11,000 cell-surface receptors with a KD of 0.03 ± 0.02 μg/ml. There appears to be one
class of binding site, and no apparent cooperativity. Native AprA inhibits the binding of rAprA to
aprA- cells with a Ki of 0.03 μg/ml, suggesting that the binding kinetics of rAprA are similar to those
of native AprA. The proliferation of cells lacking CrlA, a cAMP receptor-like protein, or cells lacking
CfaD are not affected by rAprA. Surprisingly, both cell types still bind rAprA.
Conclusion:  Together, the data suggest that AprA functions as an autocrine proliferation-
inhibiting factor by binding to cell surface receptors. Although AprA requires CfaD for activity, it
does not require CfaD to bind to cells, suggesting the possibility that cells have an AprA receptor
and a CfaD receptor, and activation of both receptors is required to slow proliferation. We
previously found that crlA- cells are sensitive to CfaD. Combined with the results presented here,
this suggests that CrlA is not the AprA or CfaD receptor, and may be the receptor for an unknown
third factor that is required for AprA and CfaD activity.
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Background
Much remains to be understood about the mechanisms
that regulate the size of a tissue. In some cases, it appears
that secreted diffusible factors allow cells in a group to
sense the size of the group [1,2]. As the number of cells
secreting the factor increases, the concentration of the fac-
tor increases [1,3]. The cells sense the concentration of the
factor, allowing them to sense the size of the group of
cells. If the factor inhibits cell proliferation, the resulting
negative feedback loop could effectively stop proliferation
once a specific group or tissue size is reached. The group
or tissue size would then be determined by how much fac-
tor the cells secrete, the diffusion properties of the factor,
and how sensitive the cells are to the factor. There are a
few examples of this sort of negative feedback loop. For
example, myostatin is a protein secreted by muscle cells,
and myostatin concentrations rise as the amount of mus-
cle in the body increases [4]. Myostatin inhibits myoblast
proliferation, which keeps the amount of muscle in the
body at a relatively constant level [5]. Mutation or disrup-
tion of myostatin results in abnormally large muscles
[6,7]. Another example of a negative feedback loop is thy-
roid size regulation. Thyroid cells secrete thyroid hor-
mone, which inhibits the release of thyroid-stimulating
hormone [8] from the pituitary. TSH functions to stimu-
late the growth of the thyroid. Thus, if the thyroid is dam-
aged, thyroid hormone levels would fall, allowing more
TSH release to promote thyroid growth [9]. A third exam-
ple of a negative feedback loop involves regulation of adi-
pose tissue within the human body. The leptin protein is
secreted by adipocytes and signals the amount of adipose
tissue present in the body [10,11]. High leptin levels sig-
nal to the body that appetite is satisfied, which decreases
adipose tissue accumulation to complete the feedback
loop.
There are many tissues where there is evidence for the
existence of a secreted factor that inhibits cell proliferation
to regulate tissue size, but the identity of the factor and its
signal transduction pathway is unknown. For example, in
mammals the liver has the ability to regenerate to the cor-
rect size if any portion of the liver is removed, and this
appears to be mediated by an unknown factor that is
secreted into the blood [12]. The spleen is another exam-
ple of a tissue whose size appears to be negatively regu-
lated by unknown secreted factors [13]. Identifying these
factors and their signal transduction pathways will aid in
our understanding of tissue size regulation.
Dictyostelium discoideum is an excellent model system to
study secreted factors and the regulation of proliferation
and group size. Dictyostelium  is a haploid unicellular
eukaryote that feeds on soil bacteria. There are several
secreted signals whose extracellular concentration is
sensed by Dictyostelium cells to, in turn, sense the local
density or number of other Dictyostelium cells. When cells
starve, they stop dividing and begin secreting an 80 kDa
glycoprotein called conditioned medium factor (CMF)
[3,14-18]. As more and more cells in a population starve,
the extracellular CMF concentration rises. When there is a
high percentage of starved cells, as indicated to the cells by
a high extracellular concentration of CMF, the cells aggre-
gate to form multicellular structures called fruiting bodies.
The aggregating cells form dendritic streams flowing
toward a common center. To regulate the size of the fruit-
ing bodies, the streams break up into groups if there are
too many cells in a stream [19]. Cells sense if there are too
many cells in a stream by sensing the concentration of
counting factor (CF), a protein complex secreted by the
aggregating cells [20-25].
CF is a 450 kDa complex of at least 4 different proteins
[20,23,26-28]. Partially purified CF contains 8 proteins,
and we have been systematically identifying which are
true CF components and which are contaminants. We
identified two proteins, AprA and CfaD, in the partially
purified CF preparation that are not CF components
[29,30]. AprA and CfaD are components of a 150 kDa
complex and appear to bind to each other [30]. Disrup-
tion of either aprA or cfaD results in cells that have an
abnormally high proliferation rate, while overexpression
of either protein slows proliferation [29,30]. Adding
either 10 ng/ml immunoprecipitated native AprA (at the
time, we had not found conditions to make recombinant
AprA) [29], or 20 ng/ml or higher concentrations of
recombinant CfaD [30], also slows cell proliferation.
Recombinant CfaD however does not affect the prolifera-
tion of aprA- cells, suggesting that CfaD needs the presence
of AprA to inhibit proliferation [30]. Neither AprA nor
CfaD affect growth rates per nucleus (effectively the mass
increase per hour of cells) [29,30]. Because of the finite
amount of available nutrients in a given patch of soil, and
because cells will soon starve after they reach a high cell
density, we have hypothesized that the functions of AprA
and CfaD are to slow proliferation without slowing
growth as the cells reach high density, so that when the
cells do starve, the cells will tend to be large and have a rel-
atively large store of nutrients [29,30].
While studying novel proteins with similarities to G-pro-
tein-coupled receptors, Raisley et al. [31] found that cells
lacking CrlA, a putative a G protein coupled receptor, pro-
liferate faster than wild type cells. Interestingly, we found
that compared to its effect on wild-type cells, recombinant
CfaD weakly inhibits the proliferation of crlA- cells [30].
This suggested that CrlA potentiates, but is not necessary
for, CfaD signal transduction.
We recently found conditions in which we can express
recombinant AprA (rAprA) [30]. In this report, we show
that rAprA slows the proliferation of wild-type and aprA-
cells, but has no effect on cfaD- or crlA- cells. However,BMC Biochemistry 2009, 10:4 http://www.biomedcentral.com/1471-2091/10/4
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rAprA binds to all four cell types, suggesting that CfaD and
CrlA are necessary for AprA signal transduction, and that
CrlA is a receptor for a different factor that regulates the
ability of AprA to act as a chalone.
Methods
Cell culture
Wild-type Ax2, aprA- strain DB60T3-8 [29], cfaD- strain
DB27C-1 [30], and crlA- strain JH557 [31] were cultured
following Brock et al. [20] in HL5 medium (Formedium
Ltd., Norwich, England). The growth of NC4 on bacteria
was done as described in [30]. Calculation of doubling
times was done as previously described [29].
Recombinant AprA and CfaD Expression and Purification
Recombinant AprA (rAprA) and recombinant CfaD
(rCfaD) were prepared following Bakthavatsalam et al.
[30]. The concentrations of the purified proteins were
determined as described in Gao et. al., [32].
Quantification of secreted AprA
The conditioned growth medium samples used for the
AprA quantitation were aliquots of the samples we previ-
ously used to measure the accumulation of CfaD [30],
allowing a direct comparison of the amount of AprA and
the amount of CfaD secreted by cells. Samples of the con-
ditioned growth media were run on 4–15% acrylamide
gels (Biorad Laboratories, Hercules, CA) along with differ-
ent known concentrations of rAprA. Western blots were
stained with affinity-purified anti-AprA antibodies as
described previously [29]. The AprA bands were then
scanned and analyzed using ImageJ http://
rsb.info.nih.gov/ij/. The concentration of secreted AprA at
each cell density was quantified by comparing against the
known concentrations of rAprA.
Proliferation inhibition by rAprA or conditioned growth 
medium
To test the biological activity (cell proliferation inhibition
activity) of rAprA or conditioned growth medium (pre-
pared from wild-type cells grown to 1.2 × 107 cells/ml,
where the measured rAprA concentration in the condi-
tioned growth medium is 0.3 μg/ml), cells were grown in
HL5 media to a density of 2 × 106 cells/ml, collected by
centrifugation at 1,500 × g for 3 minutes, and resus-
pended in HL5 media to 5 × 105 cells/ml. Cells were then
counted before and after 12 hours of incubation with
rAprA (or an equal volume of buffer as a control) or con-
ditioned growth medium (or an equal volume of HL5 as
a control). A sigmoidal dose-response curve
was then fit to the data to obtain Max and EC50 using
nonlinear regression with Prism (GraphPad software, San
Diego, CA). In Table 1, Max is called 'proliferation as per-
cent of control at high rAprA'. The units/ml of prolifera-
tion-inhibiting activity was defined as the fold dilution of
added rAprA or conditioned growth medium that caused
a 20% decrease in the density of cells after the 12-hour
incubation. The units/ml was calculated using the Max
and EC50 values obtained from the above curve fitting,
and solving for rAprA concentration with percent prolifer-
ation set to 80. For a known concentration of AprA, the
units/ml of activity could then be converted to units/μg.
Determination of optimal binding time for rAprA
To determine the saturation binding time of rAprA, cells
were grown to a density of 2 × 106 cells/ml. Cells were col-
lected by centrifugation at 1,500 × g for 3 minutes. Cells
were briefly washed twice in ice cold HL5 and were resus-
pended in ice cold HL5 to a final concentration of 1.0 ×
107 cells/ml and kept on ice. 0.5 μl of 300 μg/ml rAprA
was added to 500 μl of cells, and this was gently mixed on
a rotator at 4°C for 0, 1, 2, 5, 10, or 30 minutes. Cells were
collected after the indicated times by centrifugation at
10,000 × g for 30 seconds and washed briefly in 500 μl of
ice cold HL5. Following the wash, the cells were resus-
pended in 100 μl of SDS sample buffer and heated at
Percent proliferation
Max
EC50 rAprA c =−
+ − 100
11 0 ((log( )) (log( o oncentration)))
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Table 1: rAprA and wild-type conditioned growth medium slow the proliferation of wild-type (WT) and aprA- cells.
rAprA WT conditioned growth medium (CGM)
Cell type Activity, units/μg Proliferation as percent 
of control at high rAprA
Activity, units/ml Proliferation as percent 
of control at high CGM
Activity, units/μg AprA
WT 3.7 ± 0.9 71 ± 1 1.5 ± 0.5 64 ± 8 4.9 ± 1.7
aprA- 10.7 ± 2.8 70 ± 1 1.4 ± 0.5 60 ± 6 4.5 ± 1.7
cfaD- 0 ± 0 97 ± 1 ND ND ND
crlA- 0 ± 0 97 ± 1 ND ND ND
Cells of the indicated strain were grown in the presence of different concentrations of rAprA, and cells were counted after 12 hours. After fitting 
sigmoidal dose response curves (Figure 2), the activity of rAprA and the proliferation as a percent of control at high concentrations of rAprA were 
calculated. Similar fits were done for cells grown in different dilutions of wild-type conditioned growth medium (Figure 3). The activity of the AprA 
in conditioned growth medium was calculated using the observed AprA concentration of 0.3 μg/ml. All values are mean ± SEM from 3 independent 
experiments. ND indicates not determined.BMC Biochemistry 2009, 10:4 http://www.biomedcentral.com/1471-2091/10/4
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95°C before loading 10 μl onto a 4–15% gel (Biorad).
Different concentrations of rAprA were used as a standard
on the same gel, and proteins were transferred onto a
PVDF membrane (Immobilin-P, Millipore corporation,
Bedford, MA). A duplicate gel was stained with Coomassie
to verify that there were roughly equal amounts of protein
in each sample. To detect rAprA (which contains a myc
tag), the blots were stained with a 1:10,000 dilution of
anti-myc antibodies (Bethyl laboratories, Montogomery,
TX) in 25 mM Tris/HCl pH 7.4, 150 mM NaCl/0.1%
Tween-20 for 1 hour, and subsequent steps for Western
blotting were done following [29]. The rAprA bands on
the autoradiograph were scanned and the binding experi-
ment intensities were compared against the standards to
determine the concentration of bound rAprA. An associa-
tion binding curve
Bound rAprA = Bmax(1-e-kt)
where t is time was then fit to the data using Prism.
Steady state binding
A binding assay was performed as described above except
that the cells were incubated with different concentrations
of rAprA for 10 minutes at 4°C. One- and two- site bind-
ing curves with and without cooperative binding were
then fit to the data using Prism.
Competitive binding
For competitive binding assays, wild-type conditioned
growth medium (CGM) was prepared as described previ-
ously [33]. The concentration of AprA in the conditioned
medium was measured as described above. A binding
assay was performed as described above with the excep-
tion that aprA- cells were used, and were resuspended in
pre-chilled mixtures of HL5 medium and wild type condi-
tioned growth medium before adding 150 ng/ml of
rAprA. After 10 minutes of incubation, the amount of
bound rAprA was determined as described above. A sig-
moidal dose-response curve
where BT is the maximal rAprA binding in the competi-
tion assay and IC50 is the concentration of native AprA
that causes 50% inhibition of the AprA binding, was then
fit to the data using nonlinear regression with Prism. The
Ki for the binding inhibition was then calculated from the
IC50 using the equation of Cheng and Prusoff [34].
Results
Recombinant AprA is bioactive
AprA is a secreted signal in Dictyostelium cells that slows
cell proliferation [29]. To determine the extracellular con-
centration of AprA, we expressed and purified recom-
binant AprA (rAprA) for use as a reference standard
(Figure 1A). The rAprA appeared as a single band at 60
kDa, which roughly corresponds to the sum of the pre-
dicted molecular mass of the his/myc tag on the rAprA
(5.3 kD) and the predicted mass of the secreted portion of
the AprA polypeptide backbone (53.1 kDa). Since the
observed mass of the secreted portion of native AprA is 60
kDa [29], the observed mass of rAprA suggests that the
secreted native AprA contains ~5–7 kDa of posttransla-
tional modification, presumably glycosylation. Western
blots of conditioned growth medium electrophoresed
alongside known quantities of rAprA were stained with
affinity-purified anti-AprA antibodies. We observed an
increase in the accumulation of extracellular AprA with
cell density during the growth of wild-type cultures (Fig-
ure 1B). As the cultures reached saturation at ~1.2 × 107
cells/ml, the AprA concentration rose to 0.3 μg/ml. This
corresponds to an accumulation of 2.5 × 10-8 μg/cell. Sim-
ilar assays showed that at a density of 2 × 106 cells/ml,
both cfaD- and crlA- cells had accumulated 0.6 ± 0.1 μg/ml
of extracellular AprA (data not shown), indicating that
loss of CfaD or CrlA causes cells to accumulate, compared
to wild-type cells, roughly ten times more extracellular
AprA.
It took 16 hours for wild-type cultures to proliferate from
0.5 × 106 cells/ml to 1.3 × 106 cells/ml, and during this
time the extracellular AprA concentration increased by
0.021 ± 0.001 μg/ml (mean ± SEM, n = 3). Assuming that
Bound rAprA BT
BT
IC50 native AprA concent =−
+ − 11 0 ((log( )) (log( r ration)))
⎛
⎝
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⎞
⎠
⎟
The concentration of extracellular AprA increases with cell  density Figure 1
The concentration of extracellular AprA increases 
with cell density. A) An SDS-polyacrylamide gel of recom-
binant AprA (left lane) and molecular mass standards (right 
lane) was stained with Coommassie.B) Using different con-
centrations or recombinant AprA to make a standard curve, 
Western blots were used to determine the extracellular 
concentration of AprA as a function of cell density. Values 
are mean ± SEM (n = 3). The absence of error bars indicates 
that the error was smaller than the plot symbol.
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during log-phase growth the cell density ρ = Noekt, we see
that with No = 0.5 × 106 cells/ml, k = 0.060/hour. Assum-
ing a constant AprA accumulation rate/cell/hour = X, then
Solving for X, we find that between 0.5 × 106 and 1.3 × 106
cells/ml, the extracellular AprA accumulation rate is 1.6 ×
10-9 μg/cell/hour, or 2.6 × 10-11 μg/cell/minute, or 260
molecules of AprA/cell/minute. Similar calculations were
done for the other cell density ranges shown in Figure 1B,
as well as for the extracellular CfaD concentrations shown
in Figure 3 of [30]. As shown in Table 2, with the assump-
tion that there is no breakdown of extracellular AprA or
CfaD, the accumulation rate of extracellular AprA per cell
per hour fluctuates as the cell density in the population
increases, with a general tend of decreasing as the cells
approach saturation density. Conversely, the accumula-
tion rate of extracellular CfaD per cell per hour increases
as the cell density in the population increases (Table 2).
In the wild, Dictyostelium cells grow on soil surfaces. The
parental strain used in these studies is an axenic strain
derived from an isolate from North Carolina called NC4
[35]. We found that when NC4 strains grow on lawns of
bacteria on agar plates, they secrete both CfaD and AprA,
and that NC4 cells growing on bacteria accumulate
approximately 4 times more CfaD per cell than Ax2 cells
at 1.2 × 107 cells/ml in shaking culture [30]. Using rAprA
to generate a standard curve, we found that when there are
3 × 107 NC4 cells on an agar plate, the agar contains 2.0 ±
0.1 μg of AprA (mean ± SEM, n = 3). This corresponds to
an accumulation of 6.6 × 10-8 μg/cell, which is approxi-
mately 2.6 times higher than the accumulation for Ax2
cells at stationary phase. The data thus suggest that in the
natural environment, cells accumulate somewhat more
AprA and CfaD than axenic cells in shaking culture.
We previously observed that immunoprecipated native
AprA slows the proliferation of wild-type and aprA- cells
[29]. To determine if any eukaryote-specific posttransla-
tional modification such as glycosylation is part of the
AprA active site, we added rAprA to cells. After 12 hours,
rAprA at concentrations at and above 0.1 μg/ml signifi-
cantly slowed the proliferation of wild-type and aprA- cells
(Figure 2A and Table 1). A recombinant version of the
human serum protein Serum Amyloid P, made with the
same expression vector in the same bacterial cell line, as
well as bovine serum albumin, had no effect on cell pro-
liferation (data not shown). Even at high concentrations
(64 μg/ml), rAprA was only able to slow the proliferation
of wild-type and aprA- cells rather than completely arrest
their proliferation (Figure 2A). The doubling times we
observed for wild-type and aprA- cells were 12.7 and 9.1
hours respectively, essentially identical to what we previ-
ously observed [29]. At 1 μg/ml rAprA, the doubling time
for wild-type cells was 19.3 hours, and at 4 μg/ml the dou-
bling time was 24.5 hours, similar to the 23.3 hour dou-
bling time we observed for cells overexpressing AprA [29].
Interestingly, rAprA had essentially no ability to slow the
proliferation of crlA- or cfaD- cells. These results demon-
strate that rAprA is bioactive, that if AprA is glycosylated,
the glycosylation is not essential for bioactivity, and sug-
gest that CrlA and CfaD are required for the ability of
rAprA to slow cell proliferation.
CfaD and AprA potentiate each other's ability to slow 
proliferation
Like AprA, CfaD is a protein secreted by growing Dictyos-
telium cells that slows cell proliferation [30]. CfaD appears
to bind to AprA and requires AprA for bioactivity. To
determine if rCfaD potentiates the activity of rAprA, we
added mixtures of rAprA and rCfaD to cells. CfaD accu-
mulates to ~0.08 μg/ml when cells are at 1.2 × 107 cells/
ml, while AprA accumulates to ~0.3 μg/ml at this density.
As a rough comparison, we thus added 2:1 w/w mixtures
of rAprA:rCfaD to wild type cells (Figure 2B). A fit of a sig-
moidal dose response curve indicated that at high concen-
trations, the mixture is able to slow proliferation to 72 ±
3% of control (mean ± SEM, n = 3). This is not signifi-
cantly different from the amount that high concentrations
21
0
16
 ng/ml =∫ Xd t r
Table 2: The accumulation of AprA and CfaD as a function of cell density.
AprA accumulation CfaD accumulation
Density range, 106 cells/ml 10-10 μg/cell/hour Molecules/minute 10-10 μg/cell/hour Molecules/minute
0.5 – 1.3 15.4 ± 0.6 260 ± 10 < 0.004 < 1
1.3 – 3.0 2.9 ± 0.1 49 ± 2 0.7 ± 0.1 11 ± 2
3.0 – 5.5 8.5 ± 0.7 140 ± 10 1.0 ± 0.2 17 ± 3
5.5 – 9.2 7.3 ± 0.4 120 ± 7 1.2 ± 0.1 19 ± 2
9.2 – 12 1.3 ± 0.3 22 ± 5 3.6 ± 0.2 59 ± 4
The accumulation values are derived from the AprA quantitation in Figure 1 and from the CfaD quantitation in Figure 3 of [30]; both figures used 
the same set of samples for quantitation. Values are mean ± SEM from 3 separate experiments.BMC Biochemistry 2009, 10:4 http://www.biomedcentral.com/1471-2091/10/4
Page 6 of 12
(page number not for citation purposes)
rAprA slows cell proliferation Figure 2
rAprA slows cell proliferation. A) Different concentrations of rAprA were added to the indicated cell types, and after 12 
hours cells were collected and counted. WT is wild-type. Values are mean ± SEM (n = 3). The absence of error bars indicates 
that the error was smaller than the plot symbol. The lines are sigmoidal dose response curve fits to the data; the dashed line is 
the fit to aprA-. The inhibition of wild type and aprA- proliferation is significant with p < 0.01 at 0.1 μg/ml and higher rAprA con-
centrations (1-way ANOVA, Dunnett's test). B) A 2:1 mixture of rAprA and rCfaD was added to wild-type cells as in A above, 
so that at, for instance, 0.32 μg/ml rAprA there was an additional 0.16 μg/ml rCfaD. Values are mean ± SEM (n = 3). The line is 
a sigmoidal dose response curve fit to the data. The inhibition of wild type proliferation is significant with p < 0.05 at 0.02 μg/
ml rAprA/0.01 μg/ml rCfaD and higher concentrations (t test).
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of rAprA or rCfaD can slow proliferation (Table 1 and
[30]). rAprA slows proliferation to 80% of control at
~0.27 μg/ml (Figure 2A and Table 1), while rCfaD slows
proliferation to 80% of control at 0.05 μg/ml [30]. The
mixture slows proliferation to 80% of control at 0.045 μg/
ml rAprA/0.022 μg/ml rCfaD (Figure 2B). This suggests
that the presence of CfaD decreases the concentration of
AprA needed to slow proliferation, and vice versa.
The conditioned growth medium from wild-type cells
slows aprA- cell proliferation, whereas conditioned growth
medium from aprA- cells lacks this activity, indicating that
AprA is a key component of the proliferation-inhibiting
activity in wild-type conditioned growth medium [29]. To
compare the proliferation-inhibiting activity of recom-
binant AprA to the AprA-associated activity in condi-
tioned growth medium, cells were grown in different
dilutions of conditioned growth medium collected from
wild-type cells at 1.2 × 107 cells/ml. After 12 hours, wild-
type conditioned growth medium at concentrations
above 30% significantly slowed the proliferation of wild
type and aprA- cells (Figure 3 and Table 1). Using the
observed AprA concentration in conditioned growth
medium (collected from wild-type cells at 1.2 × 107 cells/
ml) of 0.3 μg/ml (Figure 1), the AprA activity, as measured
in units/μg of the AprA in wild-type conditioned growth
medium, on wild-type or aprA- cells was roughly similar to
the activity of rAprA on wild-type cells; the differences
were not statistically significant (p > 0.05, 1-way ANOVA,
Tukey's test) (Table 1). However, at high concentrations,
the wild-type conditioned growth medium caused a
somewhat greater inhibition of proliferation than high
concentrations of rAprA (Figures 2 and 3 and Table 1).
Together, the results suggest that rAprA has roughly the
same bioactivity as native AprA, but that there may be
additional factors in conditioned growth medium that
slow cell proliferation.
Recombinant AprA binds to Dictyostelium cells
To determine if AprA is sensed by cell surface receptors, we
examined the binding of rAprA to cells. The binding
assays were done in HL5 growth medium, as we previ-
ously observed that we could measure binding of CMF to
cells in this medium [16]. After trying a variety of binding
times and concentrations to establish rough time and con-
centration conditions for the assays (Figure 4 and data not
shown), the time course of rAprA binding was examined
to establish steady state conditions for further binding
assays. The amount of rAprA bound to cells reached near
steady state levels by 10 minutes (Figure 5). Interestingly,
even though rAprA was unable to inhibit the proliferation
of  cfaD-  and  crlA-  cells, rAprA bound to these cells.
Although there appeared to be differences in the binding
rates, the difference in the binding time constant k
between all pairs of cell types was not significant (p >
0.05, 1-way ANOVA, Tukey's test). In addition, although
it appeared that there were differences in the amount of
rAprA bound at 10 and 30 minutes to the different cell
types, the difference between all pairs of cell types was not
significant (p > 0.05, 1-way ANOVA, Tukey's test).
A key property of binding is that it is saturable. To exam-
ine whether the binding of rAprA to cells is saturable, cells
were incubated with different concentrations of rAprA
and the amount of bound rAprA was measured after 10
minutes. For wild-type and crlA- cells, the binding of
rAprA appeared to saturate above a free rAprA concentra-
tion of 0.4 μg/ml (Figure 6 and Table 3). There appeared
to be a higher level of binding to aprA- and cfaD- cells, the
binding appeared to roughly saturate, and there appeared
to be a lower KD for binding to these two cell lines. The
binding appeared to be specific, as competition with 10
μg/ml of BSA had no discernable effect on binding (data
not shown). For all four cell lines, binding curves were fit
using nonlinear regression with an equation for one-site
binding. F-tests comparing these fits to fits with a two-site
binding model, or fits to binding models with a variable
Hill coefficient, indicated that for each of the four cell
lines there did not appear to be two classes of binding sites
or cooperative binding; the Hill coefficient for binding to
Wild-type conditioned growth medium slows cell prolifera- tion Figure 3
Wild-type conditioned growth medium slows cell 
proliferation. Conditioned growth medium was collected 
and diluted with fresh growth medium to the indicated con-
centrations. Wild-type (WT) and aprA- cells were then grown 
in the mixed media, and cells were counted after 12 hours. 
Values are mean ± SEM (n = 3). The absence of error bars 
indicates that the error was smaller than the plot symbol. 
Lines are curve fits of a sigmoidal dose response curve; the 
dashed line is the fit to aprA-. The inhibition of WT and aprA- 
proliferation is significant with p < 0.05 at 30% and higher 
conditioned growth medium concentrations (1-way 
ANOVA, Dunnett's test).
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wild-type cells was 1.0. Taken together, the data suggests
that rAprA shows saturable binding to cells.
To compare the cell surface binding of rAprA to that of
native AprA, we measured the inhibition of rAprA binding
to aprA- cells by different concentrations of native AprA,
using wild-type conditioned growth medium from cells at
1.2 × 107 cells/ml as a source of native AprA. As the con-
centration of wild-type conditioned growth medium in
the binding assay increased, the amount of rAprA binding
to aprA- cells decreased (Figure 7). Using the equation of
Cheng and Prusoff [34] and the observed AprA concentra-
tion of 0.3 μg/ml in wild type conditioned growth
medium from cells at 1.2 × 107 cells/ml, we found that
native AprA had an inhibition constant (Ki) of 0.03 μg/ml,
which is similar to the 0.03 μg/ml KD for the binding of
rAprA to aprA- cells. Taken together, the data suggest that
the binding affinity of rAprA to aprA- cells is roughly sim-
ilar to that of native AprA.
Discussion
Dictyostelium cells appear to regulate cell proliferation by
secreting and sensing AprA and CfaD [29,30]. We found
here that at 21°C, wild-type cells accumulate 260 mole-
cules/cell/minute of extracellular AprA at low cell densi-
ties, and this decreases to 22 molecules/cell/minute as
cells approach saturation density. Conversely, the CfaD
accumulation rate appears to increase from less than 1
molecule/cell/minute at low density to 59 molecules/cell/
minute near saturation density. These changes in accumu-
lation rates as the cell density in a culture increases may be
due to changes in nutrient or waste product levels, or
changes in levels of signals such as AprA and CfaD. These
accumulation rates are in the range of the 12 molecules/
cell/minute for CMF [36], the 60 molecules/cell/minute
for the accumulation of CF by wild-type cells [32], and the
250 molecules/cell/minute we observed for the accumula-
tion of CF by smlA- cells [20].
Binding of rAprA to cells Figure 4
Binding of rAprA to cells. For a rAprA binding assay, wild-type cells were incubated for 10 minutes with the indicated con-
centrations ("Added to cells" in ng/ml) of myc-tagged rAprA. The cells were then washed to remove unbound rAprA, and 
were solubilized in SDS sample buffer. A western blot of the solubilized cells electrophoresed alongside different amounts of 
myc-tagged rAprA ("Standards") was stained with anti-myc antibodies (upper panel) while a duplicate gel of the cell samples 
was stained with Coomassie (lower panel). The heavy band in the Coomassie-stained samples is actin.
0.5      2        4       6       0       20     40     80    120   160   200   400   800   1600  ng
Anti-Myc
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Using the AprA secretion rate of 49 molecules/cell/minute
for cells harvested at 2 × 106 cells/ml, we can calculate
that, if the binding assays had been done at 21°C, in our
10-minute binding assays wild-type cells would accumu-
late 4.9 × 10-4 μg/ml of AprA. This is less than the lowest
concentration of rAprA used for the binding curves (other
than the buffer control) and well below the measured KD's
(Table 3). We saw that, at the density that we harvested
cells for the binding assays, crlA- and cfaD- cells accumu-
lated roughly 10 times more AprA than wild-type cells.
This could be due to an increased AprA secretion rate or a
decreased AprA degradation rate, or some combination of
the two. Assuming a ten-times higher AprA secretion rate,
crlA- and cfaD- cells would accumulate 4.9 × 10-3 μg/ml of
AprA in the 10-minute binding assays. This is still below
the observed KD's. At 4°C (the condition for the binding
assays), the secretion rate will be even lower than at 21°C,
so the amount of AprA secreted by cells during the bind-
ing assay should not have strongly interfered with the
binding assay results.
Cells overexpressing Apra or CfaD still proliferate, albeit
slowly, and recombinant CfaD slows but does not stop
the proliferation of cells [29,30]. Like CfaD, rAprA slows
but does not stop cell proliferation, even when combined
with recombinant CfaD at concentrations three times
higher than seen in the conditioned growth medium of
stationary phase cells (Figures 2A and 2B). One can imag-
ine that in the wild, a Dictyostelium cell might find itself in
a small enclosed space where secreted factors might build
up to very high concentrations, and having high concen-
trations of a chalone completely stop proliferation would
be disadvantageous. The observed response of cells to
AprA and CfaD (slowing but not stopping proliferation)
thus might allow cells to increase their mass and protein
content as they reach a high density, without incurring the
risk of unnecessarily stopping proliferation under some
conditions.
The response of wild-type and aprA- cells is nonlinear: it
takes approximately 0.01 μg/ml rAprA to decrease the cell
density at 12 hours by 10%, approximately 0.1 μg/ml to
decrease the density by an additional 10%, and more than
1 μg/ml to cause a further ~10% decrease (Figure 2A).
rAprA appeared to have a higher activity (in units/μg)
when added to aprA- cells compared to its activity on wild-
type cells (Figure 2A and Table 1). A qualitative explana-
tion for this is that wild-type cells are accumulating extra-
cellular AprA while aprA-  cells are not, so in the
proliferation assay the wild-type cells are effectively start-
ing at a higher extracellular AprA concentration compared
to the aprA- cells. Since our definition of a unit of AprA
activity is the inverse of the amount of AprA needed to
inhibit proliferation by 20% at 12 hours, and given the
nonlinear response of cells to AprA, it would thus take
more AprA to slow wild-type cells by an additional 20%
compared to the amount of AprA needed to slow aprA-
cells by 20%. This would then predict that AprA would
appear to have a lower activity on wild-type cells com-
Time course of rAprA binding to cells Figure 5
Time course of rAprA binding to cells. Cells of the indi-
cated strains (WT is wild-type) were incubated with 150 ng/
ml of rAprA for the indicated times at 4°C. Cells were col-
lected and the bound myc-tagged rAprA was quantitated by 
western blots (staining for the myc tag), using known 
amounts of rAprA as standards. The plot symbols are the 
same as those in Figure 2. Values are mean ± SEM (n = 3). 
Lines are curve fits of an association binding curve; the 
dashed line is the fit to aprA-.
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Cells bind physiological concentrations of rAprA Figure 6
Cells bind physiological concentrations of rAprA. 
Cells of the indicated strains (WT is wild-type) were incu-
bated with different concentrations of rAprA. After 10 min-
utes, cells were collected and the bound rAprA was 
measured as in Figure 5. The plot symbols are the same as in 
Figure 2. Values are mean ± SEM (n = 3). For the 60 kDa 
rAprA, a bound rAprA value of 1.0 ng/5 × 105 cells is equiva-
lent to 2.0 × 104 molecules/cell. The lines are curve fits to a 
one-site binding model with no cooperative binding.
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pared to its activity on aprA- cells, which is what we
observed.
Immunoprecipitated native extracellular AprA at 10 ng/
ml significantly slowed the proliferation of wild-type and
aprA- cells [29], whereas higher concentrations of rAprA
are needed to significantly slow proliferation. Native AprA
has a higher molecular mass than recombinant AprA and
thus appears to have some posttranslational modifica-
tion, presumably glycosylation. This difference in post-
translational modifications may be the explanation for
why native AprA appears to be more potent than recom-
binant AprA.
rAprA and rCfaD appear to potentiate each other's ability
to inhibit proliferation (Figures 2A and 2B and Table 1).
However, conditioned growth medium, which contains
both AprA and CfaD, appears to have the same activity as
rAprA, and thus has effectively less proliferation inhibit-
ing activity than one would predict. This suggests that
there may be some proliferation promoting activity in
conditioned growth medium that counteracts the effects
of AprA and CfaD. This proliferation promoting activity
may well be due to a secreted growth factor activity (the
factor has not been identified) that has been observed in
Dictyostelium conditioned growth medium [37].
Wild-type cells show roughly steady-state binding after 10
minutes of incubation with rAprA, which is similar to the
binding kinetics observed for countin [32] and condi-
tioned medium factor (CMF) to Dictyostelium cells [16].
We found that recombinant AprA binds to wild-type cells
with a KD of ~2.6 nM. This is stronger than the ~150 nM
KD observed for folate binding to Dictyostelium cells [38],
but quite similar to the 2.1 nM KD that we observed for
CMF binding [16], and weaker than the 490 pM for CF50
binding [27], or 60 pM for countin binding [32]. Depend-
ing on the cell type, we observed ~6 – 9 × 104 AprA bind-
ing sites/cell. Although this is much higher than the ~50–
60 countin or CF50 binding sites/cell [27,32], this is sim-
ilar to the ~6 × 104 folate binding sites/cell [38] or ~4 ×
104 CMF binding sites/cell [16]. Together, this suggests
that the binding timecourse, KD, and number of binding
sites/cell for AprA binding to cells are all within the range
seen for the binding of other ligands to Dictyostelium cells.
At 107 cells/ml, where the extracellular AprA concentra-
tion is 0.3 μg/ml, solving for the number of occupied cell-
surface receptors using our observed KD and Bmax for
wild-type cells, we see that there will be ~40,000 occupied
receptors, or roughly 2/3 of the receptors will be occupied.
This would then allow a strong activation of pathways
downstream from the AprA receptor.
Although not statistically significant, it appears that aprA-
and cfaD- cells have somewhat more AprA receptors than
wild-type or crlA- cells, and that the AprA receptors in aprA-
and cfaD- cells have a lower KD (stronger binding) than the
receptors in wild-type or crlA- cells. A possible explanation
for this is that there may be some degree of AprA-induced
receptor desensitization and down regulation in wild-type
and crlA- cells, and that CfaD is necessary for this effect.
Table 3: The measured KD and Bmax for the binding of rAprA to vegetative cells.
Cell type KD, μg/ml KD, nM Bmax, ng/5 × 105 cells Bmax, molecules/cell
WT 0.16 ± 0.05 2.6 ± 0.8 3.1 ± 0.4 62,000 ± 8,000
aprA- 0.03 ± 0.02 0.5 ± 0.3 4.6 ± 0.6 92,000 ± 11,000
cfaD- 0.04 ± 0.03 0.7 ± 0.5 4.5 ± 0.7 91,000 ± 14,000
crlA- 0.11 ± 0.04 1.9 ± 0.6 3.3 ± 0.3 66,000 ± 7,000
For each cell line, the KD in μg/ml and the Bmax in ng/5 × 105 cells was obtained from the curve fits in Figure 6. The KD in nM and Bmax in 
molecules/cell were calculated using a molecular mass of 60 kDa for rAprA. All values are mean ± SEM, n = 3. For both the the KD's and the Bmax's, 
the difference between any two cell lines is not significant (p > 0.05, 1-way ANOVA, using either Tukey's or Bonferroni's test).
Endogenous AprA competes with rAprA for binding to cells Figure 7
Endogenous AprA competes with rAprA for binding 
to cells. The binding of rAprA to aprA- cells was measured in 
the presence of the indicated concentrations of wild-type 
conditioned growth medium from cells at 107 cells/ml, where 
the AprA concentration is 0.3 μg/ml. Values are mean ± SEM 
(n = 4). The line is a curve fit of a sigmoidal dose response 
curve.
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AprA and CfaD appear to be part of the same extracellular
complex, and the presence of AprA is required for rCfaD
to be able to slow proliferation [30], and conversely the
presence of CfaD is needed for rAprA to slow proliferation
(Figure 2A). However, rAprA shows roughly normal bind-
ing to cells in the absence of CfaD (Figures 4 and 5). This
suggests that CfaD does not regulate AprA's proliferation-
slowing activity by regulating its ability to bind to cells,
but rather CfaD activates some pathway downstream of
AprA binding that permits AprA signaling. This is strik-
ingly similar to what we observed for countin and CF50,
two protein components of the extracellular signal CF
[27]. Countin and CF50 need each other for activity, but
still bind to cells in the other's absence [27]. rAprA also
needs the presence of the receptor-like protein CrlA to
slow proliferation (Figure 2A), but surprisingly rAprA
shows roughly normal binding to crlA- cells (Figures 5 and
6). rCfaD slows the proliferation of crlA- cells, although to
a lesser extent than rCfaD slows wild-type or cfaD- cells
[30]. This suggests that CrlA is neither the AprA nor the
CfaD receptor, but rather is part of a different pathway
that for unknown reasons regulates the ability of AprA
and CfaD to function as chalones to slow proliferation.
Conclusion
Together, the data suggest that AprA functions as an auto-
crine proliferation-inhibiting factor by binding to cell sur-
face receptors. Like CfaD, the concentration of AprA
increases with cell density, and also like CfaD, AprA slows
but does not completely stop proliferation. Although
AprA requires CfaD for activity, and the two factors poten-
tiate each other's activity, AprA does not require CfaD to
bind to cells, suggesting the possibility that cells have an
AprA receptor and a CfaD receptor, and activation of both
receptors is required to slow proliferation. We previously
found that crlA- cells are sensitive to CfaD. Combined with
the results presented here, this suggests that CrlA is not the
AprA or CfaD receptor, and may be the receptor for an
unknown third factor that is required for AprA and CfaD
activity.
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